TRIDENT LIFELINE
|
The Current P/S Ratio of TRIDENT LIFELINE is 6.04.
Share Price | ₹249.5 | Mar 12,2025 |
Market Cap | ₹286.9 Cr | |
Sales-TTM | ₹47.5 Cr | TTM-Consolidated Results |
Price/Sales | 6.04x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of TRIDENT LIFELINE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹286.9 Cr] as on Mar 12,2025
(/) Sales [ ₹47.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.04x ]
Thus, for TRIDENT LIFELINE , the investors are currently willing to pay '6.04 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TRIDENT LIFELINE !
The chart below summarizes the trend in P/S Ratio of TRIDENT LIFELINE over the last five years.
Historical PS (Price/Sales) ratio chart of TRIDENT LIFELINE
PS Ratio Performance Analysis for TRIDENT LIFELINE
- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2024 to Mar2022 averaged 3.33x.
- TRIDENT LIFELINE 's operated at median p/e ratio of 4.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 5.77x.
- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does TRIDENT LIFELINE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
TRIDENT LIFELINE | 47.5 | 6.04 | 286.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.79 | 402,213.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.57 | 150,403.0 |
CIPLA LTD | 26,981.2 | 4.35 | 117,415.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.27 | 104,791.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 2.95 | 92,228.2 |
MANKIND PHARMA LTD | 11,641.0 | 7.69 | 89,504.8 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.02 | 89,454.2 |
LUPIN LTD | 22,001.6 | 4.08 | 89,719.4 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.08 | 64,288.9 |
ABBOTT INDIA LTD | 6,243.2 | 10.15 | 63,371.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TRIDENT LIFELINE 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.08x |
Max industry PS | 16.57x |
Median industry PS | 6.04x |
Average industry PS | 6.82x |
You may also like the below Video Courses